These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 15921064

  • 1. Economic analysis of the implementation of autologous transfusion technologies throughout England.
    Dixon S, James V, Hind D, Currie CJ.
    Int J Technol Assess Health Care; 2005; 21(2):234-9. PubMed ID: 15921064
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A prospective study investigating the cost effectiveness of intraoperative blood salvage during liver transplantation.
    Phillips SD, Maguire D, Deshpande R, Muiesan P, Bowles MJ, Rela M, Heaton ND.
    Transplantation; 2006 Feb 27; 81(4):536-40. PubMed ID: 16495800
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The use of cell salvage in routine cardiac surgery is ineffective and not cost-effective and should be reserved for selected cases.
    Attaran S, McIlroy D, Fabri BM, Pullan MD.
    Interact Cardiovasc Thorac Surg; 2011 May 27; 12(5):824-6. PubMed ID: 21297148
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Preoperative use of recombinant human erythropoietin in pediatric orthopedics: a decision model for long-term outcomes.
    Vitale MG, Roye BD, Ruchelsman DE, Roye DP.
    Spine J; 2007 May 27; 7(3):292-300. PubMed ID: 17482112
    [Abstract] [Full Text] [Related]

  • 8. Intraoperative blood salvage in vascular surgery - worth the effort?
    Freischlag JA.
    Crit Care; 2004 May 27; 8 Suppl 2(Suppl 2):S53-6. PubMed ID: 15196326
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Costs associated with blood transfusions in Sweden--the societal cost of autologous, allogeneic and perioperative RBC transfusion.
    Glenngård AH, Persson U, Söderman C.
    Transfus Med; 2005 Aug 27; 15(4):295-306. PubMed ID: 16101807
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness analysis and innovation.
    Jena AB, Philipson TJ.
    J Health Econ; 2008 Sep 27; 27(5):1224-36. PubMed ID: 18619695
    [Abstract] [Full Text] [Related]

  • 12. Effects of the National Institute for Health and Clinical Excellence's technology appraisals on prescribing and net ingredient costs of drugs in the National Health Service in England.
    Dietrich ES.
    Int J Technol Assess Health Care; 2009 Jul 27; 25(3):262-71. PubMed ID: 19619344
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A, Shepard D, Horgan C, Ritter G.
    J Ment Health Policy Econ; 2007 Mar 27; 10(1):3-13. PubMed ID: 17417043
    [Abstract] [Full Text] [Related]

  • 17. Autologous blood predonation in cardiac surgery.
    Dietrich W.
    Transfus Clin Biol; 2007 Dec 27; 14(6):526-9. PubMed ID: 18424148
    [Abstract] [Full Text] [Related]

  • 18. High tech, low yield: doctors' use of medical innovation.
    Burke G.
    J Am Health Policy; 1994 Dec 27; 4(1):48-53. PubMed ID: 10131581
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Estimation of economic costs associated with transfusion dependence in adults with MDS.
    Frytak JR, Henk HJ, De Castro CM, Halpern R, Nelson M.
    Curr Med Res Opin; 2009 Aug 27; 25(8):1941-51. PubMed ID: 19552620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.